Non-alcoholic fatty liver disease
In Non-alcoholic fatty liver disease there is accumulation of excessive fat in the liver cells. It’s often associated with metabolic syndrome, including obesity, diabetes, high blood pressure, and dyslipidemia. Non-alcoholic fatty liver disease ranges from simple steatosis, which is relatively benign, to Non-Alcoholic Steatohepatitis (NASH), a more severe form that includes inflammation and liver cell damage. Over time, NASH can lead to fibrosis, cirrhosis, and an increased risk of liver cancer. The exact etiology of Non-alcoholic fatty liver disease (NAFLD) is not fully known. But it is known to be closely linked to insulin resistance and metabolic dysfunctions. Diagnosis often involves blood tests, imaging studies, and sometimes liver biopsy. Management of NAFLD usually focuses on lifestyle changes like diet, exercise, weight loss, and controlling associated metabolic conditions.
Non-alcoholic fatty liver disease
Latest Posts
-
Fatty liver could be caused by E-cigarette smoke.
Researchers found that regular e-cigarette exposure may lead to an accumulation of fat in the liver. Their conclusion was based on an animal study on mice. These research findings are presented at ENDO 2018, the Endocrine Society’s 100th…
-
Researcher discover role of protein CPEB4 in development of fatty liver
The scientists at IRB Barcelona discovered the role of a protein CPEB4 in the pathogenesis of nonalcoholic steatohepatitis (fatty liver). This condition generally leads to chronic inflammation, which can trigger fibrosis, cirrhosis and ultimately liver cancer. This…
-
New approach to treating non-alcoholic fatty liver disease
Researchers from the University of South Carolina, Duke University, the University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park has discovered a new pathway in the liver that opens the door to treating non-alcoholic fatty…
You must be logged in to post a comment.